504 related articles for article (PubMed ID: 26067104)
1. Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling.
Zuckermann M; Hovestadt V; Knobbe-Thomsen CB; Zapatka M; Northcott PA; Schramm K; Belic J; Jones DT; Tschida B; Moriarity B; Largaespada D; Roussel MF; Korshunov A; Reifenberger G; Pfister SM; Lichter P; Kawauchi D; Gronych J
Nat Commun; 2015 Jun; 6():7391. PubMed ID: 26067104
[TBL] [Abstract][Full Text] [Related]
2. Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and piggyBac transposase lineage labeling.
Chen F; Rosiene J; Che A; Becker A; LoTurco J
Development; 2015 Oct; 142(20):3601-11. PubMed ID: 26400094
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional up-regulation of Gadd45a in Patched-associated medulloblastoma.
Kappler R; Hess I; Schlegel J; Hahn H
Int J Oncol; 2004 Jul; 25(1):113-20. PubMed ID: 15201996
[TBL] [Abstract][Full Text] [Related]
4. Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts.
Pöschl J; Stark S; Neumann P; Gröbner S; Kawauchi D; Jones DT; Northcott PA; Lichter P; Pfister SM; Kool M; Schüller U
Acta Neuropathol; 2014 Jul; 128(1):123-36. PubMed ID: 24871706
[TBL] [Abstract][Full Text] [Related]
5. Identification of variants in primary and recurrent glioblastoma using a cancer-specific gene panel and whole exome sequencing.
Virk SM; Gibson RM; Quinones-Mateu ME; Barnholtz-Sloan JS
PLoS One; 2015; 10(5):e0124178. PubMed ID: 25950952
[TBL] [Abstract][Full Text] [Related]
6. Loss of suppressor-of-fused function promotes tumorigenesis.
Lee Y; Kawagoe R; Sasai K; Li Y; Russell HR; Curran T; McKinnon PJ
Oncogene; 2007 Sep; 26(44):6442-7. PubMed ID: 17452975
[TBL] [Abstract][Full Text] [Related]
7. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
[TBL] [Abstract][Full Text] [Related]
8. PTEN Signaling in the Postnatal Perivascular Progenitor Niche Drives Medulloblastoma Formation.
Zhu G; Rankin SL; Larson JD; Zhu X; Chow LM; Qu C; Zhang J; Ellison DW; Baker SJ
Cancer Res; 2017 Jan; 77(1):123-133. PubMed ID: 27815386
[TBL] [Abstract][Full Text] [Related]
9. Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes.
Alcantara Llaguno SR; Wang Z; Sun D; Chen J; Xu J; Kim E; Hatanpaa KJ; Raisanen JM; Burns DK; Johnson JE; Parada LF
Cancer Cell; 2015 Oct; 28(4):429-440. PubMed ID: 26461091
[TBL] [Abstract][Full Text] [Related]
10. Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice.
Tong WM; Ohgaki H; Huang H; Granier C; Kleihues P; Wang ZQ
Am J Pathol; 2003 Jan; 162(1):343-52. PubMed ID: 12507917
[TBL] [Abstract][Full Text] [Related]
11. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched.
Wetmore C; Eberhart DE; Curran T
Cancer Res; 2001 Jan; 61(2):513-6. PubMed ID: 11212243
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
[TBL] [Abstract][Full Text] [Related]
13. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
14. Brain tumours: classification and genes.
Collins VP
J Neurol Neurosurg Psychiatry; 2004 Jun; 75 Suppl 2(Suppl 2):ii2-11. PubMed ID: 15146033
[No Abstract] [Full Text] [Related]
15. Estrogen Receptor-β Up-Regulates IGF1R Expression and Activity to Inhibit Apoptosis and Increase Growth of Medulloblastoma.
Cookman CJ; Belcher SM
Endocrinology; 2015 Jul; 156(7):2395-408. PubMed ID: 25885794
[TBL] [Abstract][Full Text] [Related]
16. Review: personalized mice: modelling the molecular heterogeneity of medulloblastoma.
Markant SL; Wechsler-Reya RJ
Neuropathol Appl Neurobiol; 2012 Jun; 38(3):228-40. PubMed ID: 22070547
[TBL] [Abstract][Full Text] [Related]
17. Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression.
Thomas WD; Chen J; Gao YR; Cheung B; Koach J; Sekyere E; Norris MD; Haber M; Ellis T; Wainwright B; Marshall GM
Oncogene; 2009 Apr; 28(13):1605-15. PubMed ID: 19234491
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors.
Pang JC; Dong Z; Zhang R; Liu Y; Zhou LF; Chan BW; Poon WS; Ng HK
Int J Cancer; 2003 May; 105(1):76-81. PubMed ID: 12672033
[TBL] [Abstract][Full Text] [Related]
19. Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival.
Kang YJ; Balter B; Csizmadia E; Haas B; Sharma H; Bronson R; Yan CT
Nat Commun; 2017 Jan; 8():14013. PubMed ID: 28094268
[TBL] [Abstract][Full Text] [Related]
20. Glioma models: new GEMMs add "class" with genomic and expression correlations.
Maire CL; Ligon KL
Cancer Cell; 2011 Mar; 19(3):295-7. PubMed ID: 21397851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
